These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Is MGMT promoter methylation to be considered in the decision making for recurrent surgery in glioblastoma patients? Pala A; Schmitz AL; Knoll A; Schneider M; Hlavac M; König R; Wirtz CR; Coburger J Clin Neurol Neurosurg; 2018 Apr; 167():6-10. PubMed ID: 29425743 [TBL] [Abstract][Full Text] [Related]
5. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles. Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389 [TBL] [Abstract][Full Text] [Related]
6. Influence of supramarginal resection on survival outcomes after gross-total resection of IDH-wild-type glioblastoma. Vivas-Buitrago T; Domingo RA; Tripathi S; De Biase G; Brown D; Akinduro OO; Ramos-Fresnedo A; Sabsevitz DS; Bendok BR; Sherman W; Parney IF; Jentoft ME; Middlebrooks EH; Meyer FB; Chaichana KL; Quinones-Hinojosa A J Neurosurg; 2022 Jan; 136(1):1-8. PubMed ID: 34087795 [TBL] [Abstract][Full Text] [Related]
7. Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article. Bloch O; Han SJ; Cha S; Sun MZ; Aghi MK; McDermott MW; Berger MS; Parsa AT J Neurosurg; 2012 Dec; 117(6):1032-8. PubMed ID: 23039151 [TBL] [Abstract][Full Text] [Related]
8. Extent of resection affects prognosis for patients with glioblastoma in non-eloquent regions. Kow CY; Kim BJH; Park TI; Chen JCC; Vong CK; Kim JY; Shim V; Dragunow M; Heppner P J Clin Neurosci; 2020 Oct; 80():242-249. PubMed ID: 33099354 [TBL] [Abstract][Full Text] [Related]
9. Partial resection offers an overall survival benefit over biopsy in MGMT-unmethylated IDH-wildtype glioblastoma patients. Hallaert G; Pinson H; Vanhauwaert D; Van den Broecke C; Van Roost D; Boterberg T; Kalala JP Surg Oncol; 2020 Dec; 35():515-519. PubMed ID: 33152608 [TBL] [Abstract][Full Text] [Related]
10. Pseudoprogression in glioblastoma patients: the impact of extent of resection. Park HH; Roh TH; Kang SG; Kim EH; Hong CK; Kim SH; Ahn SS; Lee SK; Choi HJ; Cho J; Kim SH; Lee KS; Suh CO; Chang JH J Neurooncol; 2016 Feb; 126(3):559-66. PubMed ID: 26608521 [TBL] [Abstract][Full Text] [Related]
11. DNA methylation subclass receptor tyrosine kinase II (RTK II) is predictive for seizure development in glioblastoma patients. Ricklefs FL; Drexler R; Wollmann K; Eckhardt A; Heiland DH; Sauvigny T; Maire C; Lamszus K; Westphal M; Schüller U; Dührsen L Neuro Oncol; 2022 Nov; 24(11):1886-1897. PubMed ID: 35511473 [TBL] [Abstract][Full Text] [Related]
12. Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma. Molinaro AM; Hervey-Jumper S; Morshed RA; Young J; Han SJ; Chunduru P; Zhang Y; Phillips JJ; Shai A; Lafontaine M; Crane J; Chandra A; Flanigan P; Jahangiri A; Cioffi G; Ostrom Q; Anderson JE; Badve C; Barnholtz-Sloan J; Sloan AE; Erickson BJ; Decker PA; Kosel ML; LaChance D; Eckel-Passow J; Jenkins R; Villanueva-Meyer J; Rice T; Wrensch M; Wiencke JK; Oberheim Bush NA; Taylor J; Butowski N; Prados M; Clarke J; Chang S; Chang E; Aghi M; Theodosopoulos P; McDermott M; Berger MS JAMA Oncol; 2020 Apr; 6(4):495-503. PubMed ID: 32027343 [TBL] [Abstract][Full Text] [Related]
13. Predictive value of MGMT promoter methylation on the survival of TMZ treated Chai R; Li G; Liu Y; Zhang K; Zhao Z; Wu F; Chang Y; Pang B; Li J; Li Y; Jiang T; Wang Y Cancer Biol Med; 2021 Feb; 18(1):272-282. PubMed ID: 33628600 [TBL] [Abstract][Full Text] [Related]
14. Glioblastoma surgery with and without intraoperative MRI at 3.0T. Napolitano M; Vaz G; Lawson TM; Docquier MA; van Maanen A; Duprez T; Raftopoulos C Neurochirurgie; 2014 Aug; 60(4):143-50. PubMed ID: 24975207 [TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes of concomitant chemoradiotherapy with temozolomide for newly diagnosed glioblastoma patients: A single-center analysis. Roh TH; Park HH; Kang SG; Moon JH; Kim EH; Hong CK; Ahn SS; Choi HJ; Cho J; Kim SH; Lee SK; Kim DS; Kim SH; Suh CO; Lee KS; Chang JH Medicine (Baltimore); 2017 Jul; 96(27):e7422. PubMed ID: 28682902 [TBL] [Abstract][Full Text] [Related]
16. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival. Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121 [TBL] [Abstract][Full Text] [Related]
17. The Impact of Surgery in IDH 1 Wild Type Glioblastoma in Relation With the MGMT Deregulation. Marchi F; Sahnane N; Cerutti R; Cipriani D; Barizzi J; Stefanini FM; Epistolio S; Cerati M; Balbi S; Mazzucchelli L; Sessa F; Pesce GA; Reinert M; Frattini M Front Oncol; 2019; 9():1569. PubMed ID: 32039032 [No Abstract] [Full Text] [Related]
18. Methylome analyses of three glioblastoma cohorts reveal chemotherapy sensitivity markers within DDR genes. Kessler T; Berberich A; Sadik A; Sahm F; Gorlia T; Meisner C; Hoffmann DC; Wick A; Kickingereder P; Rübmann P; Bendszus M; Opitz C; Weller M; van den Bent M; Stupp R; Winkler F; Brandes A; von Deimling A; Platten M; Wick W Cancer Med; 2020 Nov; 9(22):8373-8385. PubMed ID: 32991787 [TBL] [Abstract][Full Text] [Related]
19. Determining a cut-off residual tumor volume threshold for patients with newly diagnosed glioblastoma treated with temozolomide chemoradiotherapy: A multicenter cohort study. Woo PYM; Ho JMK; Tse TPK; Lam SW; Mak CHK; Chan DTM; Lee MWY; Wong ST; Chan KY; Poon WS J Clin Neurosci; 2019 May; 63():134-141. PubMed ID: 30712777 [TBL] [Abstract][Full Text] [Related]
20. Surgery for Glioblastoma: Impact of the Combined Use of 5-Aminolevulinic Acid and Intraoperative MRI on Extent of Resection and Survival. Coburger J; Hagel V; Wirtz CR; König R PLoS One; 2015; 10(6):e0131872. PubMed ID: 26115409 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]